PhenoPath is recruiting a full-time pathologist with expertise in solid tumor pathology and interest in, and experience with, diagnostic IHC. The successful candidate will participate in sign-out of clinical consultative pathology cases, interpretation of directed laboratory testing, and evaluation of material associated with contract research activities. The successful candidate will also be expected to develop a leadership role in the IHC laboratory with oversight of laboratory operations, new antibody validations, and staff management. Other duties include participation in: PhenoPath committees, such as Quality Management, Compliance, Competency Assessment Steering Committee, etc.; review and development of PhenoPath informational/marketing materials; presentations to staff and PhenoPath clients; and preparation of data for manuscript submissions and presentation at national meetings.
Board certification in anatomic pathology with comprehensive working knowledge of IHC techniques is required. The ideal candidate will also show proficiency with other laboratory techniques, including fluorescence in situ hybridization (FISH) and polymerase chain reaction (PCR).
PhenoPath Laboratories is a national reference laboratory based in Seattle, WA, serving pathologists and oncologists with expertise in histologic assessment of tumors, and integration of state-of-the art ancillary pathology services (immunohistochemistry [IHC], flow cytometry, fluorescence in situ hybridization [FISH], PCR-based molecular techniques, and cytogenetics, covering both Hematopathology... and solid tumor pathology. PhenoPath is a unique pathologist owned and directed laboratory, with a collaborative and cooperative working environment. The pathologsits and staff are all dedicated to providing outstanding clinical and research services, education of pathology and oncology colleagues, and development of new tests as they are demonstrated to be useful in tumor analysis or as biomarkers.